The number of genomic loci identified to be associated with psychiatric disorders have substantially increased over the last decade. Alongside developments in polygenic embryo screening (PES; or PGT-P), the use of polygenic risk scores (PRS) to predict the genetic likelihood of polygenic traits (e.g., height, skin tone) and conditions (e.g., psychiatric disorders), it is now possible to screen embryos intended for invitro fertilization for genetic risk of psychiatric conditions such as schizophrenia or autism spectrum disorders.